WASHINGTON (AP) - The U.S. is recommending a “pause” in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots. In a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said it was investigating clots in six women in the days after vaccination, in combination with reduced platelet counts. More than 6.8 million doses of the J&J vaccine have been administered in the U.S. U.S. federal distribution channels, including mass vaccination sites, will pause the use of the J&J shot, and states and other providers are expected to follow.
Stay with WAAY 31 for the latest on this story.
Posted: Apr 13, 2021 6:26 AM
Updated: Apr 13, 2021 6:30 AM
- Johnson & Johnson pauses Covid-19 vaccine trial after 'unexplained illness'
- CDC and FDA recommend US pause use of Johnson & Johnson's Covid-19 vaccine over blood clot concerns
- The U.S. is recommending a “pause” on the Johnson & Johnson COVID-19 vaccine
- North Alabama recipient reacts after Johnson & Johnson coronavirus vaccinations paused
- Alabama pauses use of Johnson & Johnson coronavirus vaccine after federal recommendation
- Johnson & Johnson asks FDA to authorize its Covid-19 vaccine
- Florence clinic concerned about coronavirus vaccine hesitancy after Johnson & Johnson pause
- UPDATE: US allows use of Johnson & Johnson coronavirus vaccine to resume after 11-day pause
- Huntsville pharmacist says patients still interested in Johnson & Johnson vaccine after pause
- Alabama doctors discuss Johnson & Johnson coronavirus vaccine and efficacy
Scroll for more content...